BUSINESS BRIEFING / DRUGS
Times Wire Reports
Allergan Inc. of Irvine sued Corona-based Watson Pharmaceuticals Inc., alleging infringement of a U.S. patent for Sanctura XR, a prescription medicine used to treat overactive bladder.
Allergan, and business partners Endo Pharmaceuticals Solutions Inc. and Supernus Pharmaceuticals Inc., contend in a federal court complaint that Watson plans to market a generic version of Sanctura before the patent expires in 2025.
Watson did not immediately comment.
